在超急性缺血性中风患者中影响静脉血栓溶解延迟的因素:单中心研究
1Department of Neurology, Faculty of Medicine, Universitas Padjadjaran/Dr. Hasan Sadikin General Hospital, Bandung, Indonesia.
International journal of general medicine
|June 7, 2023
概括
对于急性缺血性中风而言,静脉血栓溶解的延迟是常见的,而医院前的因素会显著影响治疗的开始. 优化医院前护理对于改善中风结果至关重要.
科学领域:
- 神经学 神经学
- 紧急医疗 紧急医疗
- 公共卫生 公共卫生
背景情况:
- 用复合组织等离子体激活剂 (r-tPA) 进行静脉血栓溶解是急性缺血性中风的标准治疗方法.
- 减少血栓溶解的时间对于改善患者的治疗结果至关重要.
- 准备时间分为医院前和医院内阶段,两者都导致延迟.
研究的目的:
- 确定导致急性缺血性中风静脉血栓溶解延迟的因素.
- 在医院环境中分析延迟血栓溶解的预测因素.
主要方法:
- 从2021年1月到2021年12月,哈桑·萨迪金医院对缺血性中风患者进行了回顾性队列研究.
- 患者被分为"延迟"和"非延迟"血栓溶解组.
- 使用后勤回归分析来确定延迟血栓溶解的独立预测因素.
主要成果:
- 在141名患者中,118名 (83.69%) 患有延迟血栓溶解.
- 国家卫生研究院中风量表 (NIHSS) 的入学分数是延迟的重要风险因素.
- 确定的独立预测因素包括年龄,发病率,女性性别和NIHSS得分,尽管并非所有都达到统计学意义.
结论:
- 性别,失脂症风险因素和到达发作是延迟血栓溶解的独立预测因素.
- 医院前的因素在整体延迟血栓溶解药物治疗中起着更为重要的作用.
- 解决医院前延误对于提高急性缺血性中风治疗的疗效至关重要.
相关概念视频
Venous Thrombosis III: Interprofessional Care
11
Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...
11
Anticoagulant Drugs: Vitamin K Antagonists and Direct Oral Anticoagulants
1.3K
Oral anticoagulants are vital tools in preventing and treating blood clotting disorders. This diverse class of medications can be categorized as vitamin K antagonists, exemplified by warfarin, and direct thrombin inhibitors (DTIs), such as dabigatran, as well as factor Xa inhibitors, including rivaroxaban.
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...
1.3K
Anticoagulant Drugs: Low-Molecular-Weight Heparins
767
Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
767
Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care
15
Diagnosing Pulmonary EmbolismDiagnosing pulmonary embolism (PE) involves clinical assessment and advanced imaging tests. The preferred diagnostic tool is the spiral (helical) CT scan or CT angiography (CTA), which uses intravenous contrast media to visualize the pulmonary vasculature and identify emboli.A ventilation-perfusion (V/Q) scan is an alternative for patients unable to receive contrast media. This scan includes both perfusion and ventilation scanning. Perfusion scanning involves...
15
Venous Thrombosis I: Introduction
14
Venous thrombosis, the most common disorder of the veins, involves the formation of a thrombus or blood clot associated with vein inflammation. It can be classified as either superficial vein thrombosis or deep vein thrombosis.Superficial Vein Thrombosis: This involves the formation of a thrombus in a superficial vein, usually the greater or lesser saphenous vein. Though less severe than deep vein thrombosis (DVT), SVT can lead to complications if untreated.Deep Vein Thrombosis (DVT): This...
14
Clot Retraction and Fibrinolysis
6.5K
After a fibrin clot is formed, the next step is clot retraction, a vital process facilitated by platelet contractile proteins, such as actin and myosin. These proteins pull the fibrin strands closer together and condense the clot. This action reduces the size of the clot, creating a smaller, denser structure that effectively seals off the damaged vessel. Clot retraction consolidates the clot and helps with wound healing by bringing the edges of the damaged blood vessel closer together.
6.5K


